P.R. Herzig & Co. Inc. held its position in shares of Stryker Corporation (NYSE:SYK) during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 3,350 shares of the medical technology company’s stock at the end of the second quarter. P.R. Herzig & Co. Inc.’s holdings in Stryker Corporation were worth $465,000 as of its most recent SEC filing.
Several other hedge funds and other institutional investors have also made changes to their positions in SYK. UBS Asset Management Americas Inc. boosted its position in Stryker Corporation by 1.7% in the fourth quarter. UBS Asset Management Americas Inc. now owns 929,571 shares of the medical technology company’s stock valued at $111,370,000 after buying an additional 15,523 shares during the period. M Holdings Securities Inc. boosted its position in Stryker Corporation by 10.9% in the fourth quarter. M Holdings Securities Inc. now owns 8,074 shares of the medical technology company’s stock valued at $967,000 after buying an additional 793 shares during the period. Becker Capital Management Inc. boosted its position in Stryker Corporation by 6.6% in the fourth quarter. Becker Capital Management Inc. now owns 3,222 shares of the medical technology company’s stock valued at $386,000 after buying an additional 200 shares during the period. Teachers Advisors LLC boosted its position in Stryker Corporation by 5.7% in the fourth quarter. Teachers Advisors LLC now owns 377,336 shares of the medical technology company’s stock valued at $45,209,000 after buying an additional 20,450 shares during the period. Finally, Kentucky Retirement Systems purchased a new position in Stryker Corporation during the fourth quarter valued at approximately $2,702,000. Hedge funds and other institutional investors own 74.25% of the company’s stock.
Shares of Stryker Corporation (NYSE:SYK) opened at 147.36 on Thursday. Stryker Corporation has a 1-year low of $106.48 and a 1-year high of $147.47. The stock has a market cap of $55.08 billion, a price-to-earnings ratio of 33.11 and a beta of 0.79. The stock’s 50 day moving average is $141.93 and its 200-day moving average is $132.74.
Stryker Corporation (NYSE:SYK) last announced its quarterly earnings results on Tuesday, April 25th. The medical technology company reported $1.48 earnings per share for the quarter, beating analysts’ consensus estimates of $1.43 by $0.05. Stryker Corporation had a return on equity of 24.26% and a net margin of 14.33%. The firm had revenue of $2.96 billion for the quarter, compared to analysts’ expectations of $2.90 billion. During the same period in the prior year, the business posted $1.24 earnings per share. The business’s revenue was up 18.4% compared to the same quarter last year. On average, analysts anticipate that Stryker Corporation will post $6.43 EPS for the current year.
The business also recently declared a quarterly dividend, which will be paid on Monday, July 31st. Shareholders of record on Friday, June 30th will be given a $0.425 dividend. This represents a $1.70 dividend on an annualized basis and a yield of 1.16%. The ex-dividend date of this dividend is Wednesday, June 28th. Stryker Corporation’s dividend payout ratio (DPR) is 38.20%.
WARNING: “P.R. Herzig & Co. Inc. Holds Stake in Stryker Corporation (NYSE:SYK)” was originally reported by Sports Perspectives and is the sole property of of Sports Perspectives. If you are reading this article on another website, it was illegally stolen and reposted in violation of United States & international copyright & trademark law. The correct version of this article can be read at https://sportsperspectives.com/2017/07/20/p-r-herzig-co-inc-holds-stake-in-stryker-corporation-nysesyk.html.
Several research analysts have commented on the stock. BMO Capital Markets reiterated a “hold” rating and set a $140.00 price target on shares of Stryker Corporation in a report on Tuesday, July 11th. Zacks Investment Research upgraded shares of Stryker Corporation from a “hold” rating to a “buy” rating and set a $163.00 target price for the company in a report on Monday. Oppenheimer Holdings, Inc. set a $135.00 target price on shares of Stryker Corporation and gave the company a “hold” rating in a report on Saturday, April 8th. Jefferies Group LLC restated a “hold” rating and issued a $132.00 target price on shares of Stryker Corporation in a report on Friday, June 30th. Finally, Morgan Stanley restated an “overweight” rating and issued a $160.00 target price (up previously from $155.00) on shares of Stryker Corporation in a report on Monday, July 10th. Three analysts have rated the stock with a sell rating, seven have assigned a hold rating and thirteen have given a buy rating to the company’s stock. The stock presently has an average rating of “Hold” and an average price target of $139.08.
In other Stryker Corporation news, insider Timothy J. Scannell sold 13,322 shares of the stock in a transaction dated Tuesday, May 2nd. The stock was sold at an average price of $135.89, for a total value of $1,810,326.58. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, insider David Floyd sold 7,381 shares of the stock in a transaction dated Monday, June 5th. The shares were sold at an average price of $144.70, for a total value of $1,068,030.70. The disclosure for this sale can be found here. Insiders sold 40,008 shares of company stock worth $5,669,088 over the last quarter. Company insiders own 7.40% of the company’s stock.
About Stryker Corporation
Stryker Corporation is a medical technology company. The Company offers a range of medical technologies, including orthopedic, medical and surgical, and neurotechnology and spine products. The Company’s segments include Orthopaedics; MedSurg; Neurotechnology and Spine, and Corporate and Other. The Orthopaedics segment includes reconstructive (hip and knee) and trauma implant systems and other related products.
Want to see what other hedge funds are holding SYK? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Stryker Corporation (NYSE:SYK).
Receive News & Ratings for Stryker Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stryker Corporation and related companies with MarketBeat.com's FREE daily email newsletter.